Challenges and recommendations for early identification of metastatic disease in prostate cancer.

Authors

• E David Crawford
• Nelson N Stone
• Evan Y Yu
• Phillip J Koo
• Stephen J Freedland
• Susan F Slovin
• Leonard G Gomella
• E Roy Berger
• Thomas E Keane
• Paul Sieber
• Neal D Shore
• Daniel P Petrylak

Publication/Presentation Date

3-1-2014

Abstract

Prostate cancer is often associated with metastases to bone and/or soft tissue. The progression to metastatic castrate-resistant prostate cancer is a seminal event in disease progression affecting treatment decisions. A multidisciplinary group was convened to review the currently available imaging guidelines for metastatic disease in prostate cancer and found no consensus on eligibility criteria, type of imaging modality, and the frequency of scanning for detecting metastatic disease. The aim of this review was to present the recommendations from the group to identify optimal strategies for early identification of metastases in patients with prostate cancer.

Volume

83

Issue

3

First Page

664

Last Page

669

ISSN

1527-9995

Published In/Presented At

Crawford, E. D., Stone, N. N., Yu, E. Y., Koo, P. J., Freedland, S. J., Slovin, S. F., Gomella, L. G., Berger, E. R., Keane, T. E., Sieber, P., Shore, N. D., Petrylak, D. P., & Prostate Cancer Radiographic Assessments for Detection of Advanced Recurrence (RADAR) Group (2014). Challenges and recommendations for early identification of metastatic disease in prostate cancer. Urology, 83(3), 664–669. https://doi.org/10.1016/j.urology.2013.10.026

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

24411213

Department(s)

Administration and Leadership

Document Type

Article